Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel

• Status: Completed
• Trial end date: 2018-06-30
• Target enrollment: 0
• Participant gender: All

Summary

Clinical study for the developed voriconazole self nano emulsifying drug delivery system intermediate gel was conducted on 30 patients with tinea versicolor infection.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sara Botros
• Treatments: Voriconazole

Criteria

Inclusion Criteria:

• Tinea Versicolor infection

Exclusion Criteria:

• concomitant treatment with other medications for the same condition being studied, TVC.

• pregnancy

• lactation

• immunocompromised patients